A study of the estimate the dispensation of drugs interacting to an outpatient population identified that during only 0.05% of the patients received co-prescriptions for drugs which could possibly lead to negative effects it possibly half of it were were given for sildenafil citrate (Silagra) and one of two different nitrates.
“I believe, this was unexpected especially on results of the study,” said Charles D. Scales, MD, scientific employee to Duke University, the study introduced yesterday.
The data for the study of 1999 will receive from one of the biggest pharmaceutical benefit management companies in the United States with the recipients in all 50 states, represents about 1.200 insurance societies.
All objections were liable to prescription checked, and at least two demands had a subset of more than 800 000 patients. From these 376 patients had prescribed two prescriptions for drugs which should never be together (class 1 Interactions) fullly.
In this group of 376 patients, 263 patients (65.9%) to submitted applications for sildenafil and a nitrate drugs, with 199 prescriptions (30.2%) for sildenafil nitro and glycerine, and 127 (19.2%) for sildenafil (Silagra) and isosorbide nitrates.
The fact counts margins of the study, that it no doctor and no tip identifiers Whether the patients really took the drugs. So because of this patient’s population was a private assurance, in the direction they become younger and have less to chronic diseases, the record is able to do really unterestimate of the true prevalence of this problem in the general population, said of Dr. Scale Urology Times .